Treatment of diffuse systemic sclerosis with hyperimmune caprine serum (AIMSPRO): a phase II double-blind placebo-controlled trial.

Ann Rheum Dis · 2014 · PMC3888595 · PMID 24067785

Europe PMC DOI

hedged sentences

0.0620

closest p · 1.2× alpha

0.0620

boldest claim

The sentences

a strong trendp=0.062so close (0.05 < p ≤ 0.1)

The difference between groups at week 26 showed a strong trend towards statistical significance (p=0.062) by the unconditional z-pooled test, figure 1 A.

also in 5,725 other papers

showed a trendno p-value reported

Lung function indices showed a trend of benefit for active treatment compared with the placebo group for those variables that reflect respiratory effort (forced vital capacity and forced expiratory volume in one second).

also in 53,322 other papers

did not reach statistical significanceno p-value reported

There were numerically more AEs in the placebo group compared with the treatment group (though it did not reach statistical significance), 154 in the placebo group and 139 in the treatment group.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.